CytoSorbents Logo
US23283X3052
A42KBG

CytoSorbents

Loading quotes...

Forecast

Buy
  12
Hold
  1
Sell
  0

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, CytoSorbents had revenue of €8.44m and net profit of -€3.87m
(EUR) June 2026
YoY
Revenue 8.44m 3.45%
Gross profit 6.18m 6.84%
Net profit -3.87m 334.29%
EBITDA -2.78m 209.11%

Fundamentals

Metric Value
Market capitalization
€11.53m
Number of shares
3.15m
52-week high/low
€16.02 - €2.53
Dividends No
Beta
1.37
P/E ratio
-0.71
PEG ratio
0.01
P/B ratio
-17.19
P/S ratio
0.35

Company profile

Name
CytoSorbents
CEO
Phillip Chan
Employees 129
🍪

Parqet  uses cookies. Learn more